Literature DB >> 6499624

Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease.

R J Chiodini, H J Van Kruiningen, W R Thayer, R S Merkal, J A Coutu.   

Abstract

A previously unrecognized Mycobacterium species was isolated from two patients with Crohn's disease. The organism is an acid-fast, mycobactin-dependent Mycobacterium that has characteristics which do not conform to any of the presently recognized species. It belongs to the Runyon group III mycobacteria and is most closely related to Mycobacterium paratuberculosis. Animal inoculation revealed pathogenicity for mice when injected intravenously or intraperitoneally, but not for rats, guinea pigs, rabbits, or chickens. The mice developed hepatic and splenic granulomas which contained numerous acid-fast mycobacteria. A 7-day-old goat which was inoculated orally with 50 mg of the organism developed both humoral and cell-mediated immunologic responses in two to three weeks and granulomatous disease of the distal small intestine, with noncaseating tuberculoid granulomas in five months. Acid-fast bacilli were not demonstrable in sections of the intestine, but a single organism was seen in each of two microgranulomas of the mesenteric lymph node. The Mycobacterium species was reisolated from the lymph node but not from intestine. Our findings raise the possibility that a Mycobacterium plays an etiologic role in at least some cases of Crohn's disease.

Entities:  

Mesh:

Year:  1984        PMID: 6499624     DOI: 10.1007/bf01317078

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

Review 1.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

2.  Aetiology of regional enteritis.

Authors:  D W Golde
Journal:  Lancet       Date:  1968-05-25       Impact factor: 79.321

3.  Bacterial L-form isolation from inflammatory bowel disease patients.

Authors:  M R Belsheim; R Z Darwish; W C Watson; B Schieven
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

4.  Further data on skin testing with mycobacterial antigens in inflammatory bowel disease.

Authors:  P R Elliott; J E Lennard-Jones; W R Burnham; S White; J L Stanford
Journal:  Lancet       Date:  1980-08-30       Impact factor: 79.321

Review 5.  Ruminant paratuberculosis (Johne's disease): the current status and future prospects.

Authors:  R J Chiodini; H J Van Kruiningen; R S Merkal
Journal:  Cornell Vet       Date:  1984-07

6.  Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease.

Authors:  W R Thayer; J A Coutu; R J Chiodini; H J Van Kruiningen; R S Merkal
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

7.  Search by immunofluorescence for antigens of Rotavirus, Pseudomonas maltophilia, and Mycobacterium kansasii in Crohn's disease.

Authors:  P J Whorwell; I W Davidson; W L Beeken; R Wright
Journal:  Lancet       Date:  1978-09-30       Impact factor: 79.321

8.  Mycobacteria as a possible cause of inflammatory bowel disease.

Authors:  W R Burnham; J E Lennard-Jones; J L Stanford; R G Bird
Journal:  Lancet       Date:  1978-09-30       Impact factor: 79.321

9.  Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease.

Authors:  R J Chiodini; H J Van Kruiningen; R S Merkal; W R Thayer; J A Coutu
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

  9 in total
  100 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.

Authors:  T S Halstensen; T E Mollnes; P Garred; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives.

Authors:  L G Wayne; D Hollander; B Anderson; H A Sramek; C M Vadheim; J I Rotter
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

Review 4.  Mycobacterium paratuberculosis as a cause of Crohn's disease.

Authors:  Adrienne L McNees; Diane Markesich; Najah R Zayyani; David Y Graham
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-10-16       Impact factor: 3.869

5.  Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium avium subsp. paratuberculosis.

Authors:  I Olsen; L J Reitan; G Holstad; H G Wiker
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 6.  Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: a review of the controversy from the clinician's perspective.

Authors:  Greg Rosenfeld; Brian Bressler
Journal:  Can J Gastroenterol       Date:  2010-10       Impact factor: 3.522

7.  Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease.

Authors:  R J Chiodini; H J Van Kruiningen; W R Thayer; J A Coutu
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Use of highly specific DNA probes and the polymerase chain reaction to detect Mycobacterium paratuberculosis in Johne's disease.

Authors:  P H Vary; P R Andersen; E Green; J Hermon-Taylor; J J McFadden
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

10.  Investigation of association of mycobacteria with inflammatory bowel disease by nucleic acid hybridization.

Authors:  H H Yoshimura; D Y Graham; M K Estes; R S Merkal
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.